Speakers

• Adam Boxer, UCSF Weill Institute for Neurosciences, San Francisco, USA
  Alexandra Durr, Sorbonne Université and Paris Brain Institute, France
  Ammar Al-Chalabi, Kings College London, UK
  David Klenerman, University of Cambridge, UK
  Feng Zhang, Broad Institute of MIT and Harvard, USA
  Henrik Zetterberg, University College London, UK
  Holly Kordasiewicz, Ionis Pharmaceuticals, San Diego, USA
  John Hardy, University College London, UK
  Jonathan Rohrer, University College London Institute of Neurology
  Karen Duff, University College London, UK
  Lorenzo Guizzaro, European Medicines Agency, Amsterdam, Netherlands
  Nick Fox, University College London, UK
  Patricia Saidon, Sociedad Neurologica Argentina, Buenos Aires, Argentina
  Rachelle Doody, Roche, Geneva, Switzerland
  Reisa Sperling, Harvard Medical School, Boston, USA
  Robert Klitzman, Columbia University, USA
  Roy Yaari, Senior Medical Advisor, Eli Lilly and Company, USA
  Sarah Tabrizi, UCL Institute of Neurology, London, UK
  Sonia Vallabh and Eric Minikel, Broad Institute, Cambridge, USA
  Sophie Leggat, Rare Dementia Support member, UK
  Timothy Miller, Washington University School of Medicine in St Louis, USA
  Virginia Lee, University of Pennsylvania, USA